Tech Company Financing Transactions
Sorriso Pharmaceuticals Funding Round
Sorriso Pharmaceuticals secured a $31 million Series A funding round on 12/23/2021. Investors included Arix Bioscience, New Enterprise Associates and private investors.
Transaction Overview
Arix Bioscience (Lead Investor) (Mark Chin)
New Enterprise Associates (Lead Investor) (Ed Mathers)
Company Information
San Diego, CA 92130
USA
Management Team
Browse more venture capital transactions:
Prev: 12/23/2021: TendedBar venture capital transaction
Next: 12/23/2021: Retool venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs